Clinical trial Recruiting at 3 sites Interventional

H1 Hip Resurfacing vs Total Hip Replacement in Hip Arthritis

Official title: The ACTIVE Trial: A Prospective Randomised Control Trial Of The H1 Implant Versus Total Hip Replacement

Run by Embody Orthopaedic Limited · NCT06162195 · Data updated 2026-11-12

A randomized trial tests whether a new H1 hip resurfacing can match or beat a cementless ceramic total hip replacement for people with hip arthritis.

Quick facts

Study typeInterventional
SexAll
Enrollment200 (estimated)
SponsorEmbody Orthopaedic Limited
Industry-sponsored
Locations3 sites (Bournemouth and 2 other locations)
StatusRecruiting
StartedJuly 21, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2036
Registry record updatedAugust 13, 2026
Trial IDNCT06162195 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with unilateral primary hip arthritis (osteoarthritis or inflammatory arthritis) who are candidates for hip arthroplasty and willing to participate long-term (up to 10 years).

Probably not a fit

Patients with very high BMI, active infection, poor bone stock, or other contraindications may not benefit and could be at higher risk.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial compares two hip replacement options for adults with hip arthritis: the H1 ceramic resurfacing implant versus a cementless ceramic-on-poly or ceramic-on-ceramic total hip replacement. Participants are assigned to one of the two procedures and followed over time to compare composite clinical success, physical activity, and patient-reported outcomes. The primary aim is to determine non-inferiority of the H1 implant for overall clinical success, with secondary goals evaluating activity levels, PROMs, safety, and patient-reported noise. Secondary analyses will also examine device- and surgery-related adverse events and other outcomes over up to 10 years of follow-up. The study enforces specific inclusion and exclusion criteria to select adults requiring unilateral primary hip arthroplasty and capable of long-term participation.

Why it matters

Potential benefit: If successful, participants and future patients may have a resurfacing option that preserves more bone and provides equal or improved function and activity levels.

How similar studies have gone: Previous resurfacing vs traditional total hip comparisons have shown mixed results; this trial tests non-inferiority in a contemporary cementless ceramic context which is less established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patient requires unilateral primary hip arthroplasty due to primary osteoarthritis, osteoarthritis secondary to e.g. trauma, avascular necrosis or developmental hip dysplasia, or inflammatory arthritis.
* Patient is willing to comply with study requirements.
* Patient plans to be available through 10 years postoperative follow-up.

Exclusion Criteria:

* Patient has a BMI greater than 40 kg/m².
* Patient has active infection or sepsis (treated or untreated).
* Patient has insufficient bone stock at the hip (\>1/3 necrosis of the femoral head or large and multiple cysts) or in general as in severe osteopenia or osteoporosis (t-score \< -2.5 as measured with BMD).
* Patient is not skeletally mature.
* Patient meets the contraindication criteria of the control device.
* Patient already has another lower limb arthroplasty or arthrodesis or will require a further lower limb arthroplasty or arthrodesis within the subsequent 2 years.
* Patient lacks capacity to consent.
* Patient is unable to understand the native language of the country where their procedure is taking place

Where it's running

  • University Hospitals Dorset NHS Foundation Trust
    Bournemouth, United Kingdom
    Recruiting
  • University Hospitals Coventry & Warwickshire
    Coventry, United Kingdom
    Recruiting
  • Royal Cornwall Hospitals NHS Trust
    Truro, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.